Bozzetti F., Terno G., Camerini E., et al. Pathogenesis and predictability of central venous catheter sepsis . Surgery1982;91:303-89.
3.
Williams WWInfection control during parenteral nutrition therapy. JPEN1985;9:735-46.
4.
Noble WCSkin carriage of the micrococcaceae. J Clin Pathol1969;22:249-53.
5.
Kloss WE, Smith PBStaphylococci. In: Lennette EH, et al. eds. Manual of clinical microbiology, 3rd ed. Washington, DC: American Society for Microbiology, 1980:83.
6.
Ebbert ML, Farraj M., Hwang LTThe incidence and clinical significance of intravenous fat emulsion contamination during infusion. JPEN1987;11:42-5.
7.
Maki DGGrowth properties of microorganisms in infusion fluid and method of detection . In: Phillips I, Meens PD, D'Arcy PF, eds. Microbiologic hazards of intravenous therapy. Lancaster , England: M.T.P. Press Ltd., 1977 : 13-47.
8.
Keammerer D. , Mayhall CG, Hall GO, et al. Microbial growth in intravenous fat emulsions. Am J Hosp Pharm1983;40:1650-3.
9.
Maki DGGrowth of microorganism in Intralipid and implications for infection control . 20th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology , 1980 (abstr.)
10.
Crocker KS, Noga R., Filibeck DJ, et al. Microbial growth comparison of five commercial parenteral lipid emulsions. JPEN1984;8:391-5.
11.
Kim CH, Lewis DE, Kumar A.Bacterial and fungal growth in intravenous fat emulsions. Am J Hosp Pharm1983;40:2159-61.
12.
D'Angio R., Quercia RA, Treiber NH, et al. The growth of microorganisms in total parenteral nutrition admixtures. JPEN1987 ;11:394-7.
13.
Scott EM, Gorman SP, Wyatt TD, et al. Growth of microorganisms in total parenteral nutrition mixtures and related clinical observations. J Clin Hosp Pharm1985;10:79-88.
14.
Dolin BJ, Davis PD, Holland TA, et al. Contamination rates of 3-in-1 total parenteral nutrition in a clinical setting. JPEN1987;11:403-5.
15.
Scheckelhoff DJ, Mirtallo JM, Ayers LW, et al. Growth of bacteria and fungi in total nutrient admixtures. Am J Hosp Pharm1986;43:73-7.
16.
Lindsay J., Thomas R., La France R., et al. Microbial growth patterns in parenteral nutrient solutions: an evaluative study. Paper presented to 42nd Annual ASHP meeting held in Reno, Nevada, June 3, 1985.
17.
Jeppson R., Johnsson M., Tingborn J.Bacterial growth properties in refrigerated all-in-one TPN mixtures . Clin Nutri1987;6:25-9.
18.
Jarvis WR, Highsmith AK, Allen JR, et al. Polymicrobial bacteremia associated with lipid emulsion in a neonatal intensive care unit. Pediatr Infect Dis1983;21:203-8.
19.
Melly MA, Meng HC, Schaffner W.Microbial growth in lipid emulsions used in parenteral nutrition. Arch Surg1975;110:1479-81.
20.
Jarvis WR, Highsmith AKBacterial growth and endotoxin production in lipid emulsion. J Clin Microbiol1984;17-20.
21.
Arnold TR, Hepler CDBacterial contamination of intravenous fluids opened in unsterile air. Am J Hosp Pharm1971;28:14-9.
22.
Deeb EN, Natsios GSContamination of intravenous fluids by bacteria and fungi during preparation and administration. Am J Hosp Pharm1971;28:764-7.
23.
Miller WA, Smith GL, Latiolais CJA comparative evaluation of compounding costs and contamination rates of intravenous admixture systems. Drug Intell Clin Pharm1971;5:51-60.
24.
Duma RJ, Warner JFDalton HPSepticemia from intravenous infusions. N Engl J Med1971;284:257-60.
Sitges Serra A., Jaurrieta E., Pallares R., et al. Clinical experience with fat-containing TPN solutions. In: Johnston IDA, ed. Advances in clinical nutrition. Boston: MTP Press, 1983:207- 12.
27.
Wade JC, Schimph SC, Newman KAStaphylococcus epidermidis : an increasing cause of infection in patients with granulocytopenia. Ann Intern Med1982 ;97:503-8.
28.
Christensen GD, Bisno AL, Parisi JT, et al. Nosocomial septicemia due to multiple antibiotic resistant Staphylococcus epidermis. Ann Intern Med1982;96:1-10.
29.
Maki DGNosocomial bacteremia. An epidemiological overview. Am J Med1981;70:719-32.
30.
Sattler FR, Foderaro JB, Abel RCStaphylococcus epidermidis bacteremia associated with vascular catheters: an important cause of febrile morbidity in hospitalized patients. Infect Control1984;5:279-83.
31.
Lowy FD, Hammen SMStaphylococcus epidermidis infections. Ann Intern Med1983;99:834-9.
32.
Winston DJ, Dudrick DV, Chapin M., et al. Coagulase-negative staphylococcal bacteremia in patients receiving immunosupressive therapy. Arch Intern Med1983;143:32-6.
33.
Sherertz RL , Falk RJ, Huffman KA, et al. Infections associated with subclavian indwelling catheters. Arch Intern Med1983 ;143:52-6.
34.
Bayston R., Penny SRExcessive production of mucoid substance in Staphylococcus SIIA: a possible factor in colonisation of goiter shunts. Dev Med Child Neurol1972;27 (suppl):25-8.
35.
Christensen GD, Simpson WA, Bisno AL, et al. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun1982;37:318-26.
36.
Christensen GD, Simpson WA, Bisno AL, et al. Experimental foreign body infections in mice challenged with slime-producing Staphylococcus epidermidis. Infect Immun1983;40:407-10.
37.
Sheth NK, Frauson TR, Sohnle PGInfluence of bacterial adherence to intravascular catheters on in-vitro antibiotic susceptibility. Lancet1985;2:1266-8.
38.
Gray ED, Peters G., Verstegan M., et al. Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response. Lancet1984;2:365-7.
39.
Peters G., Locci R., Pulverer G.Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J Infect Dis1982 ;146:479-82.
40.
Bozzetti F. , Regalia E., Pinardi L., et al, Central venous catheter sepsis: prognosis and treatment. Clin Nutr1986;5:113-6.